Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14)

SGX:T14 Ratios and Metrics

Market cap in millions SGD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 11, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,039	3,870	4,118	3,547	4,133	2,267
Market Cap Growth	9.67%	-6.01%	16.09%	-14.17%	82.27%	29.44%
Enterprise Value	4,791	3,836	3,891	3,145	3,715	1,941
Last Close Price	3.68	2.73	2.38	1.23	1.17	0.84
PE Ratio	12.28	9.29	22.42	21.17	25.32	16.93
PS Ratio	4.08	2.83	2.69	2.21	2.82	1.70
PB Ratio	3.31	2.64	3.33	2.79	2.99	1.88
P/TBV Ratio	3.44	2.75	3.56	2.96	3.16	2.00
P/FCF Ratio	21.91	25.65	40.40	32.05	28.00	23.22
P/OCF Ratio	19.87	22.39	32.13	26.94	22.85	16.68
EV/Sales Ratio	4.02	2.81	2.54	1.96	2.53	1.45
EV/EBITDA Ratio	29.04	22.97	22.06	20.58	24.96	14.51
EV/EBIT Ratio	33.45	26.51	25.46	24.10	29.82	17.40
EV/FCF Ratio	20.83	25.43	38.17	28.42	25.17	19.88
Debt / Equity Ratio	0.01	0.01	0.05	0.04	0.01	0.01
Debt / EBITDA Ratio	0.09	0.04	0.36	0.34	0.06	0.06
Debt / FCF Ratio	0.06	0.05	0.62	0.47	0.06	0.09
Asset Turnover	-	0.70	0.81	0.86	0.80	0.82
Inventory Turnover	-	2.67	3.09	3.38	2.76	2.61
Quick Ratio	1.12	1.87	1.51	1.71	1.81	1.85
Current Ratio	2.00	2.35	2.03	2.17	2.64	2.59
Return on Equity (ROE)	29.64%	30.56%	14.68%	13.37%	12.63%	11.85%
Return on Assets (ROA)	-	4.61%	5.03%	4.37%	4.23%	4.27%
Return on Capital (ROIC)	6.56%	6.50%	7.43%	6.27%	5.85%	5.96%
Return on Capital Employed (ROCE)	9.60%	9.70%	11.70%	9.80%	8.90%	9.00%
Earnings Yield	8.14%	10.77%	4.46%	4.72%	3.95%	5.91%
FCF Yield	4.56%	3.90%	2.48%	3.12%	3.57%	4.31%
Dividend Yield	8.21%	8.76%	10.02%	17.75%	9.09%	7.27%
Payout Ratio	45.50%	45.33%	88.91%	44.96%	30.17%	35.15%
Buyback Yield / Dilution	0.41%	-0.07%	0.71%	-0.94%	0.04%	0.37%
Total Shareholder Return	8.62%	8.69%	10.73%	16.81%	9.13%	7.64%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.